BioSphere Medical Schedules Third Quarter 2009 Financial Results Conference Call October 29
20 Octubre 2009 - 6:30AM
Business Wire
BioSphere Medical, Inc. (NASDAQ:BSMD), the pioneer in the
use of bioengineered microspheres to treat uterine fibroids,
hypervascularized tumors, and vascular malformations by a minimally
invasive, image-guided medical procedure called embolotherapy,
today announced that it plans to issue its financial results for
the third quarter ended September 30, 2009 on October 28 after the
close of the stock market. Management will conduct a conference
call on Thursday, October 29 at 8:30 a.m. Eastern Time to discuss
these results.
The number to dial is 1-888-563-6275 (US/Canada) or
1-706-643-3137 (International), and the conference ID is 37021211.
Please call approximately ten minutes before the call is scheduled
to begin. The live webcast will be available at the "Investors"
section of BioSphere Medical’s Web site at www.biospheremed.com. A
replay of the webcast will also be available on BioSphere Medical’s
Web site.
About BioSphere Medical, Inc.
BioSphere Medical, Inc. seeks to pioneer and commercialize
minimally invasive diagnostic and therapeutic applications based on
proprietary bioengineered microsphere technology. The Company's
core technologies, patented bioengineered polymers and
manufacturing methods, are used to produce microscopic spherical
materials with unique beneficial properties for a variety of
medical applications. BioSphere's principal focus is the use of its
products for the treatment of symptomatic uterine fibroids using a
procedure called uterine fibroid embolization, or UFE. The
Company's products continue to gain acceptance in this rapidly
emerging procedure, as well as in a number of other new and
established medical treatments.
Biosphere Medical (MM) (NASDAQ:BSMD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Biosphere Medical (MM) (NASDAQ:BSMD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Biosphere Medical (MM) (NASDAQ): 0 recent articles
Más de BioSphere Medical, Inc. Artículos de Noticias